State Farm Mutual Automobile Insurance Co. Maintains Stake in Becton, Dickinson and Company (BDX)

State Farm Mutual Automobile Insurance Co. maintained its position in Becton, Dickinson and Company (NYSE:BDX) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 190,800 shares of the medical instruments supplier’s stock at the end of the first quarter. State Farm Mutual Automobile Insurance Co. owned 0.09% of Becton, Dickinson and worth $35,000,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its position in shares of Becton, Dickinson and by 6.5% in the first quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock worth $727,863,000 after buying an additional 242,081 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Becton, Dickinson and by 1.2% in the first quarter. Wells Fargo & Company MN now owns 3,283,068 shares of the medical instruments supplier’s stock worth $602,246,000 after buying an additional 39,362 shares during the last quarter. Fundsmith LLP raised its position in shares of Becton, Dickinson and by 3.2% in the first quarter. Fundsmith LLP now owns 2,296,613 shares of the medical instruments supplier’s stock worth $421,291,000 after buying an additional 71,691 shares during the last quarter. Mawer Investment Management Ltd. raised its position in shares of Becton, Dickinson and by 1.3% in the first quarter. Mawer Investment Management Ltd. now owns 1,768,539 shares of the medical instruments supplier’s stock worth $324,418,000 after buying an additional 22,563 shares during the last quarter. Finally, Cantillon Capital Management LLC raised its position in shares of Becton, Dickinson and by 30.3% in the first quarter. Cantillon Capital Management LLC now owns 1,344,427 shares of the medical instruments supplier’s stock worth $246,622,000 after buying an additional 312,926 shares during the last quarter. 75.71% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Becton, Dickinson and Company (BDX) traded down 0.61% during midday trading on Tuesday, hitting $196.63. The stock had a trading volume of 1,150,010 shares. The firm’s 50-day moving average price is $198.24 and its 200-day moving average price is $186.80. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $206.63. The firm has a market capitalization of $41.94 billion, a PE ratio of 32.66 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $3.06 billion. During the same quarter last year, the firm earned $2.35 EPS. The company’s quarterly revenue was down 5.1% compared to the same quarter last year. On average, equities analysts predict that Becton, Dickinson and Company will post $9.46 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be given a dividend of $0.73 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.49%. Becton, Dickinson and’s dividend payout ratio is currently 83.43%.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.thestockobserver.com/2017/08/09/becton-dickinson-and-company-bdx-position-maintained-by-state-farm-mutual-automobile-insurance-co-updated-updated.html.

BDX has been the topic of several research reports. Zacks Investment Research lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Thursday, May 4th. Evercore ISI raised Becton, Dickinson and from an “in-line” rating to an “outperform” rating and upped their price target for the company from $186.00 to $200.00 in a research report on Monday, April 24th. Raymond James Financial, Inc. raised Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and dropped their price target for the company from $210.00 to $180.00 in a research report on Friday, June 30th. Royal Bank Of Canada restated a “hold” rating and set a $177.00 price objective on shares of Becton, Dickinson and in a research note on Thursday, April 13th. Finally, BidaskClub upgraded Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $194.69.

In other Becton, Dickinson and news, VP Jeffrey S. Sherman sold 28,765 shares of Becton, Dickinson and stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the transaction, the vice president now owns 70,821 shares of the company’s stock, valued at approximately $13,171,289.58. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.40% of the stock is owned by company insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Company and related companies with MarketBeat.com’s FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

nineteen + 10 =